Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Woodcock’s Passion Project: CDER Chief Shifts Duties To Lead Quality Office

Executive Summary

Deputies are taking on some of Woodcock’s usual responsibilities to allow the center director more time to oversee launch of new Office of Pharmaceutical Quality.

You may also be interested in...



US FDA’s Regulatory Affairs Office Building Case For More User Fee Funding

ORA represented only a small fraction of the user fee programs’ costs in recent years, but wants to show its importance to the review process.

Gottlieb Promotes 'Team' Work For Product Reviews

US FDA Commissioner intends to change agency's siloed structure and move reviewers into teams that will follow products pre- and post-market.

'Brilliant' and 'Steady' Jenkins Retiring From US FDA's Office of New Drugs

Implementer of many drug review changes will leave in January after nearly 32 years of public service.

Related Content

Topics

UsernamePublicRestriction

Register

PS056603

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel